Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
In the last few decades, the pathogenesis of inflammatory bowel disease (IBD) in genetically predisposed subjects susceptible to specific environmental factors has been attributed to disturbance of both the immune and non-immune system and/or to the imbalanced interactions with microbes. However, in...
Main Authors: | Federica Ungaro, Federica Rubbino, Silvio Danese, Silvia D’Alessio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01331/full |
Similar Items
-
The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies
by: Federica Ungaro, et al.
Published: (2020-07-01) -
Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
by: Tobias Schmid, et al.
Published: (2021-07-01) -
New lives given by cell death: Macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation
by: Amiram eAriel, et al.
Published: (2012-01-01) -
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
by: Antonio Recchiuti, et al.
Published: (2020-09-01) -
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
by: Elisa Isopi, et al.
Published: (2020-04-01)